142 related articles for article (PubMed ID: 15592578)
1. SEA0400: a novel sodium-calcium exchange inhibitor with cardioprotective properties.
Lee C; Hryshko LV
Cardiovasc Drug Rev; 2004; 22(4):334-47. PubMed ID: 15592578
[TBL] [Abstract][Full Text] [Related]
2. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger.
Matsuda T; Koyama Y; Baba A
J Pharmacol Sci; 2005 Mar; 97(3):339-43. PubMed ID: 15764845
[TBL] [Abstract][Full Text] [Related]
3. Development and application of Na+/Ca2+ exchange inhibitors.
Iwamoto T; Kita S
Mol Cell Biochem; 2004 Apr; 259(1-2):157-61. PubMed ID: 15124919
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.
Lee C; Visen NS; Dhalla NS; Le HD; Isaac M; Choptiany P; Gross G; Omelchenko A; Matsuda T; Baba A; Takahashi K; Hnatowich M; Hryshko LV
J Pharmacol Exp Ther; 2004 Nov; 311(2):748-57. PubMed ID: 15231867
[TBL] [Abstract][Full Text] [Related]
5. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents.
Tanaka H; Nishimaru K; Aikawa T; Hirayama W; Tanaka Y; Shigenobu K
Br J Pharmacol; 2002 Mar; 135(5):1096-100. PubMed ID: 11877314
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of SEA0400, a selective inhibitor of the Na(+)/Ca(2+) exchanger, on myocardial ischemia-reperfusion injury in rats.
Yoshiyama M; Nakamura Y; Omura T; Hayashi T; Takagi Y; Hasegawa T; Nishioka H; Takeuchi K; Iwao H; Yoshikawa J
J Pharmacol Sci; 2004 Jun; 95(2):196-202. PubMed ID: 15215644
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury.
Lee C; Dhalla NS; Hryshko LV
Can J Cardiol; 2005 May; 21(6):509-16. PubMed ID: 15917880
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.
Takahashi K; Takahashi T; Suzuki T; Onishi M; Tanaka Y; Hamano-Takahashi A; Ota T; Kameo K; Matsuda T; Baba A
Eur J Pharmacol; 2003 Jan; 458(1-2):155-62. PubMed ID: 12498920
[TBL] [Abstract][Full Text] [Related]
9. SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.
Wang J; Zhang Z; Hu Y; Hou X; Cui Q; Zang Y; Wang C
Physiol Res; 2007; 56(1):17-23. PubMed ID: 16497099
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases.
Tóth A; Kiss L; Varró A; Nánási PP
Curr Med Chem; 2009; 16(25):3294-321. PubMed ID: 19548864
[TBL] [Abstract][Full Text] [Related]
11. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models.
Matsuda T; Arakawa N; Takuma K; Kishida Y; Kawasaki Y; Sakaue M; Takahashi K; Takahashi T; Suzuki T; Ota T; Hamano-Takahashi A; Onishi M; Tanaka Y; Kameo K; Baba A
J Pharmacol Exp Ther; 2001 Jul; 298(1):249-56. PubMed ID: 11408549
[TBL] [Abstract][Full Text] [Related]
12. Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors.
Iwamoto T
J Pharmacol Sci; 2004 Sep; 96(1):27-32. PubMed ID: 15359084
[TBL] [Abstract][Full Text] [Related]
13. A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury.
Ogata M; Iwamoto T; Tazawa N; Nishikawa M; Yamashita J; Takaoka M; Matsumura Y
Eur J Pharmacol; 2003 Oct; 478(2-3):187-98. PubMed ID: 14575804
[TBL] [Abstract][Full Text] [Related]
14. The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.
Birinyi P; Tóth A; Jóna I; Acsai K; Almássy J; Nagy N; Prorok J; Gherasim I; Papp Z; Hertelendi Z; Szentandrássy N; Bányász T; Fülöp F; Papp JG; Varró A; Nánási PP; Magyar J
Cardiovasc Res; 2008 Jun; 78(3):476-84. PubMed ID: 18252759
[TBL] [Abstract][Full Text] [Related]
15. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
16. Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs.
Nagasawa Y; Zhu BM; Chen J; Kamiya K; Miyamoto S; Hashimoto K
Eur J Pharmacol; 2005 Jan; 506(3):249-55. PubMed ID: 15627435
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
[TBL] [Abstract][Full Text] [Related]
18. Block of Na(+)/Ca(2+) exchanger by SEA0400 in human right atrial preparations from patients in sinus rhythm and in atrial fibrillation.
Christ T; Kovács PP; Acsai K; Knaut M; Eschenhagen T; Jost N; Varró A; Wettwer E; Ravens U
Eur J Pharmacol; 2016 Oct; 788():286-293. PubMed ID: 27373849
[TBL] [Abstract][Full Text] [Related]
19. Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs.
Takahashi T; Takahashi K; Onishi M; Suzuki T; Tanaka Y; Ota T; Yoshida S; Nakaike S; Matsuda T; Baba A
Eur J Pharmacol; 2004 Nov; 505(1-3):163-8. PubMed ID: 15556149
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection without cardiosuppression by SEA0400, a novel inhibitor of Na+-Ca2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium.
Namekata I; Nakamura H; Shimada H; Tanaka H; Shigenobu K
Life Sci; 2005 Jun; 77(3):312-24. PubMed ID: 15878358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
